Ocugen to Participate in Upcoming July Industry Conferences
Ocugen announced its participation in three upcoming industry conferences in July 2026, including a fireside chat at the Piper Sandler Virtual Ophthalmology Day. At the ASRS annual meeting, external experts will present 1-year results from the Phase 2 ArMaDa trial of OCU410 and safety outcomes from the Phase 1/2 study.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.